ASH: BMS’s Iberdomide Shows Efficacy In Myeloma Maintenance

 
• By Alaric DeArment
  
BMS's booth at the 2025 American Society of Hematology meeting (Alaric DeArment)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from ASH

More from Conferences